ClinicalTrials.gg
CompletedNCT03343496Updated Jan 25, 2019

Simplification and Implementation of Awake Fibreoptic Orotracheal Intubation

An observational study in Anesthesia, Trachea and Intubation, sponsored by Fudan University. Completed at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2019-01-25.

Sponsored by Fudan University · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
40
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Awake fibreoptic intubation (AFOI) is a classic and standard method for some special patients which is also difficult for anesthesiologists to learn and master. The procedure is sometimes hard and often takes about 20-30 min. Most of patients have a strong sense of discomfort. Investigators conducted the research to study the simplification and feasibility of AFOI.

Read the detailed description

Many studies have studied the sedative drugs and regional anesthesia related to awake intubation. However, several problems of AFOI are existing including long operation time, patients' strong discomfort, coughing and resistance. And, to investigators' knowledge, there was a lack of a fixed procedure for the implementation of AFOI. Investigators conducted the research and aimed to study the simplification and feasibility of a new AFOI method based on years of clinical theory, practice and experience.

02

Conditions studied

  • Anesthesia
  • Trachea
  • Intubation

Browse trials for

Keywords

  • Awake fiberoptic intubation
03

In context

Tracheal Diseases

33 studies on the registry are indexed under Tracheal Diseases; 7 are open to participants now.

This study's enrollment of 40 is below the median of 288 across 10 observational studies indexed under Tracheal Diseases.

Browse Tracheal Diseases studies →

Lead sponsor

Fudan University is the lead sponsor of 1,315 studies on the registry; 643 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The trial will be performed at Zhongshan Hospital, Fudan University in Shanghai, China.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. ' physical status I-II patients
  2. Aged 18-75 years
  3. Mallampati Grade I-II
  4. 18.5-28 kg·m-2

Exclusion criteria

Exclusion Criteria:

  1. Allergic to the drugs involved in the study
  2. Neck mass or infection
  3. Drug or alcohol abuse
  4. Pregnant
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
40 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Interventions

  • ProcedureAwake fiberoptic intubation (AFOI)

    With forty patients (ASA I\~II, aged 18\~75, simulating cervical instability injury) recruited to be operated on under general anesthesia, two experienced anesthesiologists performed the whole procedures within the study. Pre anesthetic interview was taken to illustrate the procedures of tracheal intubation to the patients. The simplified method consisted of three parts: conscious sedation, regional anesthesia and intubation. The time of AFOI, rate of one-time intubation success, hemodynamic parameters, pulse oxygen saturation (SpO2), rate of amnesia of the intubation, patients' satisfaction, and relative complications were recorded accordingly.

06

What researchers measure

Primary outcomes

  1. The average total time of Awake Fiberoptic Orotracheal Intubation (AFOI)

    The time from the midazolam injection to positive end tidal CO2 acquired (Minutes)

    Time frame: End of the AFOI

  2. The rate of one-time intubation success.

    All steps are successful once (Percentage)

    Time frame: End of the AFOI

Secondary outcomes

  1. Systolic blood pressure, SBP (mmHg)

    SBP is used to assess hemodynamic fluctuations

    Time frame: During the AFOI

  2. Diastolic blood pressure, DBP (mmHg)

    DBP is used to assess hemodynamic fluctuations

    Time frame: During the AFOI

  3. Heart rate, HR (bpm)

    HR is used to assess hemodynamic fluctuations

    Time frame: During the AFOI

  4. Rate of amnesia of the intubation

    It is used to assess anterograde amnesia of midazolam

    Time frame: On the first postoperative day

  5. Ramsay sedation scale

    1= anxious or restless or both, 2 = cooperative, orientated and tranquil, 3 = responding to commands, 4 = brisk response to stimulus, 5 = sluggish response to stimulus, 6= No response to stimulus

    Time frame: During the AFOI

  6. Patients' satisfaction

    1 = excellent, 2 = good, 3 = fair, 4 = poor

    Time frame: On the first postoperative day

  7. Unexpected coughing

    Unexpected coughing was evaluated with 4 score (1=none, 2\< 3 times unexpected slight coughing comparable to 'clearing ones' throat', 3≥2 times, mild unexpected coughing lasting less than a minute, 4=persistent unexpected coughing)

    Time frame: During the AFOI

  8. Relative complications

    Such as arrhythmias, bleeding or sore throat

    Time frame: End of the surgery and the first postoperative day

  9. Vocal cord movement

    1 = open, 2 = moving, 3 = closing, 4 = closed

    Time frame: During the AFOI

  10. Hypoxic episode

    SpO2\<90%

    Time frame: During the AFOI

07

Study locations

1 site
  • Zhongshan hospital, Fudan University
    Shanghai, Shanghai 200032, China
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2017 to primary completion in Jan 2018, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 11, 2017
First posted
Nov 17, 2017
StartActual
Nov 17, 2017
Primary completionActual
Jan 30, 2018
CompletionActual
Jan 30, 2018
Last update
Jan 25, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 25, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03343496
Lead sponsor
Fudan University
Responsible party
Shengjin Ge,MD (Professor of Anesthesiology, Fudan University) — Principal investigator
First posted
Nov 17, 2017
Start date
Nov 17, 2017
Primary completion
Jan 30, 2018
Completion
Jan 30, 2018
Last update
Jan 25, 2019

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion